The role of interferon regulatory factors in atherosclerosis

Area of Science:

• Molecular biology
• Immunology
• Cardiovascular research

Background:

• Cardiovascular diseases (CVDs), primarily driven by atherosclerosis (AS), are a major global health concern.
• Transcription factors and epigenetic mechanisms are key regulators of gene expression in AS.
• Interferon regulatory factors (IRFs), initially known for interferon (IFN) responses, are increasingly recognized for their roles in immunity.

Purpose of the Study:

• To review the current understanding of Interferon regulatory factors (IRFs) in atherosclerosis (AS).
• To explore the regulatory mechanisms and roles of IRFs in AS pathogenesis.
• To identify potential therapeutic targets for AS management based on IRF functions.

Main Methods:

• Literature review and synthesis of existing research on IRFs and AS.
• Analysis of studies investigating IRF involvement in inflammation, lipid metabolism, and cell dynamics during AS.
• Examination of epigenetic regulation of IRFs in the context of AS.

Main Results:

• IRFs are critical modulators of both innate and adaptive immunity in AS.
• Evidence suggests IRFs influence key pathological processes in AS, including inflammation, lipid metabolism, cell differentiation, proliferation, and programmed cell death.
• Specific IRF family members exhibit distinct roles in AS progression.

Conclusions:

• IRFs play multifaceted roles in the pathogenesis of atherosclerosis.
• Targeting IRF pathways presents a promising therapeutic strategy for managing cardiovascular diseases.
• Further research into IRF regulatory mechanisms can uncover novel avenues for AS treatment.